$CRVL
CORVEL CORP

2023 Q3 Form 10-Q Financial Statement

#000095017023038083 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $195.5M $190.3M
YoY Change 10.2% 7.91%
Cost Of Revenue $151.3M $148.4M
YoY Change 7.03% 8.75%
Gross Profit $44.25M $41.88M
YoY Change 22.6% 5.04%
Gross Profit Margin 22.63% 22.01%
Selling, General & Admin $19.50M $16.45M
YoY Change 11.12% -11.9%
% of Gross Profit 44.07% 39.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.470M $6.364M
YoY Change 2.28% 0.71%
% of Gross Profit 14.62% 15.2%
Operating Expenses $19.50M $16.45M
YoY Change 11.12% -11.9%
Operating Profit $24.75M $25.43M
YoY Change 33.47% 19.95%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $24.71M $25.43M
YoY Change 33.27% 19.95%
Income Tax $4.816M $5.623M
% Of Pretax Income 19.49% 22.11%
Net Earnings $19.90M $19.81M
YoY Change 35.77% 18.66%
Net Earnings / Revenue 10.18% 10.41%
Basic Earnings Per Share $1.16 $1.16
Diluted Earnings Per Share $1.15 $1.14
COMMON SHARES
Basic Shares Outstanding 17.11M 17.14M
Diluted Shares Outstanding 17.35M 17.39M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $91.70M $86.59M
YoY Change 21.26% -8.18%
Cash & Equivalents $91.75M $86.59M
Short-Term Investments
Other Short-Term Assets $103.2M $97.18M
YoY Change 17.31% 14.01%
Inventory
Prepaid Expenses $13.06M $12.43M
Receivables $86.94M $84.18M
Other Receivables $0.00 $0.00
Total Short-Term Assets $281.9M $268.0M
YoY Change 13.48% 2.81%
LONG-TERM ASSETS
Property, Plant & Equipment $84.94M $84.28M
YoY Change 2.95% 0.68%
Goodwill $36.81M $36.81M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.405M $26.12M
YoY Change 76.29% 5011.35%
Total Long-Term Assets $152.2M $149.6M
YoY Change 0.49% -3.5%
TOTAL ASSETS
Total Short-Term Assets $281.9M $268.0M
Total Long-Term Assets $152.2M $149.6M
Total Assets $434.1M $417.6M
YoY Change 8.56% 0.46%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.15M $20.42M
YoY Change -9.53% 5.91%
Accrued Expenses $171.1M $167.3M
YoY Change 7.99% 6.23%
Deferred Revenue $29.17M $27.74M
YoY Change 7.84% 6.59%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $186.5M $187.7M
YoY Change 6.26% 3.49%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $25.00M $22.86M
YoY Change -1.71% -16.25%
Total Long-Term Liabilities $25.00M $22.86M
YoY Change -1.71% -16.25%
TOTAL LIABILITIES
Total Short-Term Liabilities $186.5M $187.7M
Total Long-Term Liabilities $25.00M $22.86M
Total Liabilities $211.5M $210.6M
YoY Change 4.7% 0.26%
SHAREHOLDERS EQUITY
Retained Earnings $771.4M $751.5M
YoY Change 10.73% 10.19%
Common Stock $226.6M $221.5M
YoY Change 8.95% 8.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $222.6M $207.0M
YoY Change
Total Liabilities & Shareholders Equity $434.1M $417.6M
YoY Change 8.56% 0.46%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $19.90M $19.81M
YoY Change 35.77% 18.66%
Depreciation, Depletion And Amortization $6.470M $6.364M
YoY Change 2.28% 0.71%
Cash From Operating Activities $17.99M $36.63M
YoY Change 84.82% 22.0%
INVESTING ACTIVITIES
Capital Expenditures $7.230M $5.049M
YoY Change -244.14% -39.75%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$7.230M -$5.049M
YoY Change 44.14% -39.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.610M -16.31M
YoY Change -76.03% -34.32%
NET CHANGE
Cash From Operating Activities 17.99M 36.63M
Cash From Investing Activities -7.230M -5.049M
Cash From Financing Activities -5.610M -16.31M
Net Change In Cash 5.150M 15.26M
YoY Change -127.57% -577.6%
FREE CASH FLOW
Cash From Operating Activities $17.99M $36.63M
Capital Expenditures $7.230M $5.049M
Free Cash Flow $10.76M $31.58M
YoY Change -27.05% 45.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 dei Amendment Flag
AmendmentFlag
false
CY2023Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2023Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000874866
CY2023Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q1 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2023#LiabilitiesCurrent
CY2023Q2 dei Document Type
DocumentType
10-Q
CY2023Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q2 dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
CY2023Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q2 dei Entity File Number
EntityFileNumber
0-19291
CY2023Q2 dei Entity Registrant Name
EntityRegistrantName
CORVEL CORPORATION
CY2023Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0282651
CY2023Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
5128 Apache Plume Road
CY2023Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
CY2023Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Worth
CY2023Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
76109
CY2023Q2 dei City Area Code
CityAreaCode
817
CY2023Q2 dei Local Phone Number
LocalPhoneNumber
390-1416
CY2023Q2 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.0001 Per Share
CY2023Q2 dei Trading Symbol
TradingSymbol
CRVL
CY2023Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q2 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17113737
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86593000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71329000
CY2023Q2 us-gaap Deposits Assets Current
DepositsAssetsCurrent
84755000
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
80022000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84176000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81034000
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
12426000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11385000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
267950000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
243770000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84276000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
82770000
CY2023Q2 us-gaap Goodwill
Goodwill
36814000
CY2023Q1 us-gaap Goodwill
Goodwill
36814000
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1139000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1244000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26119000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27721000
CY2023Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
552000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
224000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
723000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1380000
CY2023Q2 us-gaap Assets
Assets
417573000
CY2023Q1 us-gaap Assets
Assets
393923000
CY2023Q2 crvl Accounts And Taxes Payable
AccountsAndTaxesPayable
20419000
CY2023Q1 crvl Accounts And Taxes Payable
AccountsAndTaxesPayable
15309000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167312000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
152578000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
187731000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
167887000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22862000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23860000
CY2023Q2 us-gaap Liabilities
Liabilities
210593000
CY2023Q1 us-gaap Liabilities
Liabilities
191747000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55019773
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17113915
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54987366
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17169500
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
221486000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
218700000
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
37905858
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
37817866
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
765982000
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
748195000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
751473000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
731668000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
206980000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
202176000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
417573000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
393923000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190253000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176307000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
148375000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136438000
CY2023Q2 us-gaap Gross Profit
GrossProfit
41878000
CY2022Q2 us-gaap Gross Profit
GrossProfit
39869000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
16450000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18671000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25428000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
21198000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5623000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4507000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
19805000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16691000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17144000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17506000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17385000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17803000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
202176000
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1474000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1312000
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
17787000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
19805000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
206980000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
212395000
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1851000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1379000
CY2022Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26688000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16691000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
205628000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
19805000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
16691000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6364000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6319000
CY2023Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-13000
CY2022Q2 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-2000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1312000
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1379000
CY2023Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
436000
CY2022Q2 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
452000
CY2023Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-328000
CY2022Q2 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-344000
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3578000
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1044000
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4733000
CY2022Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4640000
CY2023Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1041000
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-4307000
CY2023Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-655000
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
30000
CY2023Q2 crvl Increase Decrease In Accounts And Taxes Payable
IncreaseDecreaseInAccountsAndTaxesPayable
2383000
CY2022Q2 crvl Increase Decrease In Accounts And Taxes Payable
IncreaseDecreaseInAccountsAndTaxesPayable
4197000
CY2023Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14734000
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
565000
CY2023Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
604000
CY2022Q2 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
79000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
36626000
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30021000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5049000
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8380000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5049000
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8380000
CY2023Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
17787000
CY2022Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26688000
CY2023Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1474000
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1851000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16313000
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24837000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15264000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3196000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71329000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97504000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86593000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
94308000
CY2023Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
333000
CY2022Q2 us-gaap Income Taxes Paid
IncomeTaxesPaid
226000
CY2023Q2 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2728000
CY2022Q2 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
5273000
CY2023Q2 crvl Accounts Receivable Due Period
AccountsReceivableDuePeriod
P30D
CY2023Q2 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190253000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
176307000
CY2023Q2 crvl Revenue Recognition Number Of Performance Obligation
RevenueRecognitionNumberOfPerformanceObligation
1
CY2023Q2 crvl Latest Duration Of Unbilled Revenue Billing
LatestDurationOfUnbilledRevenueBilling
P1Y
CY2023Q2 us-gaap Billed Contract Receivables
BilledContractReceivables
59779000
CY2023Q1 us-gaap Billed Contract Receivables
BilledContractReceivables
57218000
CY2023Q2 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
27599000
CY2023Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
26639000
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3202000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2823000
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
84176000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81034000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
26978000
CY2023Q2 crvl Contract With Customer Liability Increase Through Contracts Acquired
ContractWithCustomerLiabilityIncreaseThroughContractsAcquired
11420000
CY2023Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4533000
CY2023Q2 crvl Contract With Customer Liability Revenue Recognized From Additions
ContractWithCustomerLiabilityRevenueRecognizedFromAdditions
6127000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27738000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
27700000
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
The Company expects to recognize approximately 96% of its remaining performance obligations as revenues within one year and the remaining balance thereafter.
CY2023Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q2 us-gaap Capitalized Contract Cost Judgment
CapitalizedContractCostJudgment
The Company has an internal sales force compensation program where remuneration is based solely on the revenues recognized in the period and does not represent an incremental cost to the Company which provides a future benefit expected to be longer than one year and would meet the criteria to be capitalized and presented as unbilled receivables on the Company’s consolidated balance sheets.
CY2023Q2 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one year or less
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0281
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.36
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y3M18D
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
651857
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
108.1
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
723876
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
84.55
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
44600
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
148.89
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39471
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
75.79
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43739
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
42.69
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
485
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
149.26
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
2394
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
121.79
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
611901
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
110.1
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
722343
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
90.94
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
611901
CY2023Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P3Y3M7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
110.1
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
307078
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
79.08
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
651857
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
108.1
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39471
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
75.79
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
444
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
148.51
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
41
CY2023Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
197.16
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
611901
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
110.1
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y3M7D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
51170280
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
566840
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
107.09
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y3M
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
48336925
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
307078
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
79.08
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y6M10D
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
35164265
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
49.97
CY2022Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
1000000
CY2023Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
39000000
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
766000000
CY2023Q2 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
87992
CY2023Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
17800000
CY2023Q2 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
201.06
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17144000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17506000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17385000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17803000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
19805000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
16691000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17144000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17506000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.95
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17144000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17506000
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
241000
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
297000
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17385000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17803000
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.14
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.94
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
14653000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
15058000
CY2023Q2 crvl Income Taxes Payable Current And Uncertain Tax Positions
IncomeTaxesPayableCurrentAndUncertainTaxPositions
5766000
CY2023Q1 crvl Income Taxes Payable Current And Uncertain Tax Positions
IncomeTaxesPayableCurrentAndUncertainTaxPositions
251000
CY2023Q2 crvl Accounts And Taxes Payable
AccountsAndTaxesPayable
20419000
CY2023Q1 crvl Accounts And Taxes Payable
AccountsAndTaxesPayable
15309000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
32857000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
22170000
CY2023Q2 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
84755000
CY2023Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
80022000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
8288000
CY2023Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
8601000
CY2023Q2 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
3277000
CY2023Q1 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
3563000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
27738000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
26978000
CY2023Q2 crvl Accrued Operating Lease Liabilities
AccruedOperatingLeaseLiabilities
9303000
CY2023Q1 crvl Accrued Operating Lease Liabilities
AccruedOperatingLeaseLiabilities
9900000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1094000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1344000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
167312000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
152578000
CY2023Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12M
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2763000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
3177000
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
22000
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
24000
CY2023Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
7000
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
18000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
269000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
501000
CY2023Q2 us-gaap Lease Cost
LeaseCost
3061000
CY2022Q2 us-gaap Lease Cost
LeaseCost
3720000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
26119000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
27721000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9303000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9900000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
22862000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
23860000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
32165000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
33760000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y21D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y25D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.036
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.028
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
2758000
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3731000
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
53496000
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
54236000
CY2023Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
358000
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
358000
CY2023Q2 crvl Reductions To Right Of Use Assets Resulting From Reductions To Operating Lease Liabilities
ReductionsToRightOfUseAssetsResultingFromReductionsToOperatingLeaseLiabilities
324000
CY2022Q2 crvl Reductions To Right Of Use Assets Resulting From Reductions To Operating Lease Liabilities
ReductionsToRightOfUseAssetsResultingFromReductionsToOperatingLeaseLiabilities
6230000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7615000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8856000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
6566000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
4862000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3859000
CY2023Q2 crvl Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2653000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
34411000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2246000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
32165000
CY2023Q2 crvl Lessee Operating Lease Commitments Not Yet Commenced
LesseeOperatingLeaseCommitmentsNotYetCommenced
7300000

Files In Submission

Name View Source Status
0000950170-23-038083-index-headers.html Edgar Link pending
0000950170-23-038083-index.html Edgar Link pending
0000950170-23-038083.txt Edgar Link pending
0000950170-23-038083-xbrl.zip Edgar Link pending
crvl-20230630.htm Edgar Link pending
crvl-20230630.xsd Edgar Link pending
crvl-ex31_1.htm Edgar Link pending
crvl-ex31_2.htm Edgar Link pending
crvl-ex32_1.htm Edgar Link pending
crvl-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
crvl-20230630_cal.xml Edgar Link unprocessable
crvl-20230630_def.xml Edgar Link unprocessable
crvl-20230630_lab.xml Edgar Link unprocessable
crvl-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
crvl-20230630_htm.xml Edgar Link completed
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending